Health & Biotech
Health & Biotech
ASX medtech CardieX accelerates go-to-market strategy following strong Options take up
Health & Biotech
ASX Health Stocks: Sigma downgrades earnings, and chairman’s death at Asian American Medical
Health & Biotech
EZZ appoints veteran biotechnology industry player Glenn Cross as chairman
Health & Biotech
Osteopore granted key regulatory approval in Hong Kong
Health & Biotech
ScoPo’s Powerplays: IDT wins big on COVID vaccines, but Healthcare IPOs look exhausted
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
Health & Biotech
How Nanoveu’s innovative disinfectant tech will combat Omicron
Health & Biotech
ECS stock rises on $4.9 million Cannvalate supply deal
Health & Biotech
MGC Pharma secures $10m capital raise from US and UK investors to advance development for its lead drug candidate, CimetrA
Health & Biotech
HealthKick Podcast: ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies
Health & Biotech
ASX Health Stocks: After TGA approval in Australia, Telix now gets license to sell in Brazil
Health & Biotech
PharmAust’s upcoming Phase 1 clinical trials receive major boost with the production of smaller tablets
Health & Biotech
ASX Health Stocks: Rhythm Biosciences scores CE Mark approval, shares jump
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.